Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04656496 · ClinicalTrials.gov registry record · NA

NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors

A NA study of Cancer and Obesity, Childhood, sponsored by University of South Florida.

Recruiting
Registry status
NA
Development phase
520
Enrollment target
10
Study locations

NCT04656496: Recruiting NA study of Cancer and Obesity, Childhood, sponsored by University of South Florida.

NCT04656496 is a NA study of Cancer and Obesity, Childhood that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 520 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (85% lower). The trial reports 10 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04656496, a NA study of Cancer and Obesity, Childhood, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
NA
Development phase
520 participants
Enrollment target
10
Study locations

Study Summary

Pediatric cancer survivors are at an increased risk of excessive weight gain and reduced exercise behaviors with the potential for this risk to worsen over time. With over 80% of pediatric cancer patients living to adulthood, many pediatric cancer survivors experience long-term health consequences such as heart disease - the leading cause of death in this population. The purpose of this clinical research study is to teach parents/caregivers skills that will help prevent and reduce the problems of obesity in childhood cancer survivors. In this study, parents have the opportunity to participate in one of two web-based groups in which parents in either group will learn valuable information to improve the health of their child and of themselves.

Primary Outcome

Height and weight will be measured to obtain BMI z-score for gender and age.

Interventions

  • BEHAVIORAL NOURISH-T+
  • BEHAVIORAL Brief NOURISH-T+

Study Locations (10)

Florida

  • University of Florida Health System - Gainesville
  • University of Miami Health System - Miami
  • Nicklaus Children's Hospital - Miami
  • USF Pediatrics - Tampa

District of Columbia

  • Children's National Hospital - Washington D.C.

Georgia

  • Emory University - Atlanta

Maryland

  • Johns Hopkins Medicine - Baltimore

Missouri

  • Washington University School of Medicine - St Louis

New Jersey

  • Hackensack Meridian Health - Hackensack

Virginia

  • Virginia Commonwealth University - Richmond

Trial Details

FieldValue
Enrollment Target 520 participants
Start Date 2020-12-08
Est. Completion 2025-11-30
Phase NA
University of South Florida

252 total trials

What NCT04656496 shows while recruiting

NCT04656496 is an interventional study that assigns participants to a tested intervention. The registered 520 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (85% lower).

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which NOURISH-T+ is the first listed.

NCT04656496 lists 10 locations in 7 states (Florida, District of Columbia, Georgia).

Frequently Asked Questions

What is clinical trial NCT04656496 about?

NCT04656496 is a clinical study titled "NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors". Pediatric cancer survivors are at an increased risk of excessive weight gain and reduced exercise behaviors with the potential for this risk to worsen over time. With over 80% of pediatric cancer patients living to adulthood, many pediatric cancer survivors experience long-term health consequences s...

What is the current status of trial NCT04656496?

This trial is currently recruiting. It is a NA study. The enrollment target is 520 participants. The study started on 2020-12-08. Estimated completion is 2025-11-30.

What conditions does trial NCT04656496 study?

This clinical trial studies the following conditions: Cancer, Obesity, Childhood, Survivorship.

What interventions are being tested in trial NCT04656496?

The interventions under investigation include: NOURISH-T+ (BEHAVIORAL), Brief NOURISH-T+ (BEHAVIORAL).

Who is sponsoring clinical trial NCT04656496?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04656496 being conducted?

This trial has 10 study locations across District of Columbia, Florida, Georgia, Maryland, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04656496's enrollment target sits among peer trials

520 117th of 615 higher than 498 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02323581 · 520 participants · NA

    Endovascular Treatment of TAAA and Aortic Arch Aneurysms Using Fenestrated and Branched Stent Grafts

  • NCT05445778 · 520 participants · Phase 3

    Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer

  • NCT05498428 · 520 participants · Phase 2

    A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

  • NCT05908240 · 520 participants · NA

    Prevention of Cardiovascular Disease and Mortality in Patients With Psoriasis or Psoriatic Arthritis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04656496, the US trial registry maintained by the National Library of Medicine. NCT04656496 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.